- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 25/02 - Drugs for disorders of the nervous system for peripheral neuropathies
Patent holdings for IPC class A61P 25/02
Total number of patents in this class: 2171
10-year publication summary
66
|
80
|
115
|
150
|
202
|
166
|
207
|
201
|
183
|
99
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Takeda Pharmaceutical Company Limited | 2711 |
26 |
Shionogi & Co., Ltd. | 860 |
22 |
Daiichi Sankyo Company, Limited | 1865 |
21 |
The Regents of the University of California | 19868 |
17 |
Osaka University | 3374 |
17 |
Mitsubishi Tanabe Pharma Corporation | 579 |
15 |
Grünenthal GmbH | 573 |
14 |
Kyoto University | 2802 |
14 |
Novartis AG | 10867 |
13 |
Bristol-myers Squibb Company | 4878 |
13 |
Vertex Pharmaceuticals Incorporated | 1598 |
13 |
Inserm (institut National de La Sante et de La Recherche Medicale) | 3367 |
12 |
Ono Pharmaceutical Co., Ltd. | 434 |
12 |
Janssen Pharmaceutica N.V. | 3399 |
11 |
Toray Industries, Inc. | 6931 |
11 |
King's College London | 525 |
11 |
Tenacia Biotechnology (Hong Kong) Co., Limited | 36 |
11 |
The Trustees of Columbia University in the City of New York | 3566 |
10 |
Eurofarma Laboratorios S.A. | 35 |
10 |
Kinki University | 243 |
10 |
Other owners | 1888 |